SANGTER Energy Supplement Capsules
Recall D-1333-2022, part of FDA recall event 90675. See Distributor RFR's company page.
Distributor RFR, LLC. started this Class I drug recall on Jul 22, 2022 (voluntary: firm initiated); FDA lists it as terminated, terminated Jul 29, 2025.
- Classification: Class I
- Started: Jul 22, 2022
- Status: Terminated
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.
- Product
- SANGTER Energy Supplement Capsules, 3000mg x 7 grain, 7-count blister pack within a carton, Distributed by: Distributor RFR, LLC, (800) 519-0204 Miami 33172 FL, USA; UPC 0 705632 523285
- Quantity
- 2000 cartons
- Lots and codes
- Lot: 48656, Exp. 01/2025
- Distribution
- Retail stores in the state of FL, Nationwide in the USA, France and Canada via website sales, and Bolivarian Republic of Venezuela
- Recalling firm
- Distributor RFR, LLC., Doral, FL, United States
- How the firm notified
- Letter
- FDA classified
- Aug 9, 2022
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports